Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.

http://www.abbvieinvestor.com


ABBV $79.76 -1.48 (-1.82%)
Sector Health Care
Industry Biotech & Pharma
Market Cap 119.84 Billion
EPS -1.14 P/E Ratio 21.79
Previous Earnings Fri, Nov 2, 2018
Latest Earnings Fri, Jan 25, 2019
Dividend 5.37% / $4.28
Ex-Date Fri, Apr 12, 2019
Dividend Pay Date Wed, May 15, 2019
Dividend History 26 Payments (Quarterly)

79.76 119.84 21.79 5.37 ABBV NYSE -1.82 -10.61 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=1

Symbol Surfing has been referenced on Barrons, CNN & Investor Place.

About | Blog | Advertising | Terms | info@symbolsurfing.com

Investing Quotes #Legendary


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.

©2019 Symbol Surfing All Rights Reserved. Privacy Policy | ^Top